-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 492.55 | 494.85 | 39 |
| 30 | 491.75 | 498.15 | 100 |
| 150 | 491.55 | 498.85 | 100 |
| 21 | 490.00 | 501.00 | 10 |
| 1 | 487.20 | 550.00 | 5 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 492.55 | 494.85 | 39 |
| 30 | 491.75 | 498.15 | 100 |
| 150 | 491.55 | 498.85 | 100 |
| 21 | 490.00 | 501.00 | 10 |
| 1 | 487.20 | 550.00 | 5 |
| 0 | Total | Total | 0 |
| Open | 499.50 |
| Previous Close | 495.10 |
| Volume | 8,104.00 |
| Value (Lacs) | 39.96 |
| VWAP | 494.26 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 988 |
| High | 499.50 |
| Low | 493.00 |
| UC Limit | 594.10 |
| LC Limit | 396.10 |
| 52 Week High | 979.50 |
| 52 Week Low | 490.00 |
| Face Value | 10.00 |
| All Time High | 979.50 |
| All Time Low | 85.05 |
| 20D Avg Volume | 27,306 |
| 20D Avg Delivery(%) | 59.48 |
| Book Value Per Share | 335.34 |
| Dividend Yield | 0.37 |
| TTM EPS See historical trend | 39.94 (-17.22% YoY) |
| TTM PE See historical trend | 12.35 (Average PE) |
| P/B See historical trend | 1.48 (Low P/B) |
| Sector PE | 40.19 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
6 out of 10 years Lincoln Pharmaceuticals has given positive returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 24.79% (2024) | 12.70% | -9.39% (2023) | -5.62% | 5.37% |
Lincoln Pharma Standalone September 2025 Net Sales at Rs 163.36 crore, up 1.33% Y-o-Y Nov 24 2025 03:22 PM
Lincoln Pharma Standalone June 2025 Net Sales at Rs 154.07 crore, up 4.61% Y-o-Y Aug 07 2025 03:18 PM
Lincoln Pharma Q1 Net Profit Rises 16.93% YoY to u20b927.70 Crore Aug 07 2025 01:13 PM
Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y Jun 24 2025 01:02 PM
For last four years net profit figures in crs are 69.. 73.. 93. and 82 as against other income numbers are 10.. 22.. 34.. 22. Given capital of Rs. 20 crs even after deducting other income items from net profit amounts the resultant EPS on an average works out to more than 20. Considering FV of Rs. 10 and zero debt status and also the reserves of about Rs. 700 indicate the fundamental strength of the company. If the management succeeds in increasing sales of the company to annually cross 1000 crs the stock price will surely zoom to 1000 mark. View more
Posted by : mickychem
Repost this message
For last four years net profit figures in crs are 69.. 73.. 93. and 82 as against other income numbers are 10.. 22.. 34.. 22. Given capital of Rs. 20 crs even after deducting other income items from net profit amounts the resultant EPS on an average works out to more than 20. Considering FV of Rs. 10 and zero debt status and also the reserves of about Rs. 700 indicate the fundamental strength of the company. If the management succeeds in increasing sales of the company to annually cross 1000 crs the stock price will surely zoom to 1000 mark.
Posted by : The Fixed Income
Repost this message
Lock in a Steady 9.15% from a Trusted NBFC Bond 9.15% VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1y 10m (Maturity: 04 Nov 2027) Senior Secured | High-Return | NBFC Bond | Listed Add a reliable, secured NBFC bond to your portfolio and benefit from consistent yields with medium-term tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJDc1lRPT0=/1060-navi-finserv-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 275585 | Price 600.39 | % Traded 1.37 |
| Qty 275585 | Price 599.49 | % Traded 1.37 |
| Qty 160300 | Price 606.04 | % Traded 0.81 |
| Qty 160300 | Price 604.97 | % Traded 0.81 |
| Qty 137847 | Price 600.74 | % Traded 0.69 |
| Qty 125529 | Price 602.25 | % Traded 0.62 |
| Qty 104690 | Price 598.87 | % Traded 0.52 |
| Qty 92372 | Price 599.35 | % Traded 0.46 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharma | 493.15 | -0.39 | 987.77 | 12.35 | 1.47 | 12.25 | -46.57 | 82 | 623 | 0.00 |
| Sun Pharma | 1,805.30 | -0.71 | 433,151.94 | 41.45 | 6.00 | 15.13 | -0.45 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,473.50 | 0.07 | 171,851.09 | 69.15 | 11.48 | 14.63 | 6.19 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,785.90 | -0.26 | 128,132.06 | 59.88 | 17.07 | 25.17 | 12.63 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,520.80 | -0.01 | 122,845.85 | 22.58 | 3.94 | 16.90 | 1.51 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
